Harvey M. Golomb to Adenocarcinoma
This is a "connection" page, showing publications Harvey M. Golomb has written about Adenocarcinoma.
Connection Strength
0.250
-
Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer. 1987 Jun 15; 59(12):2016-9.
Score: 0.045
-
Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985 Mar; 89(3):378-85.
Score: 0.038
-
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
Score: 0.024
-
Estrogen receptor. Therapeutic guide in undifferentiated metastatic carcinoma in women. Arch Intern Med. 1975 Jul; 135(7):942-5.
Score: 0.020
-
Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
Score: 0.011
-
Regional accuracy of computed tomography of the mediastinum in staging of lung cancer. J Thorac Cardiovasc Surg. 1986 Apr; 91(4):498-504.
Score: 0.010
-
The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986 Mar; 91(3):344-9.
Score: 0.010
-
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients. Cancer. 1985 Nov 15; 56(10):2385-90.
Score: 0.010
-
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
Score: 0.009
-
Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
Score: 0.008
-
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
Score: 0.008
-
Guided biopsies of abnormalities on nuclear bone scans. Technique and indications. J Thorac Cardiovasc Surg. 1983 Mar; 85(3):396-403.
Score: 0.008
-
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
Score: 0.008
-
Chromosome analysis of primary large bowel tumors: a new method for improving the yield of analyzable metaphases. Cancer. 1979 Nov; 44(5):1656-64.
Score: 0.007
-
Lung cancer: A combined modality approach to staging and therapy. CA Cancer J Clin. 1979 Sep-Oct; 29(5):258-75.
Score: 0.007
-
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
Score: 0.006
-
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1976 Sep; 60(9):1225-30.
Score: 0.005
-
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
Score: 0.005
-
Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer. 1985 Oct 01; 56(7):1618-23.
Score: 0.002
-
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
Score: 0.002
-
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
Score: 0.002
-
Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
Score: 0.002
-
Sequential staging in bronchogenic carcinoma. Chest. 1979 Dec; 76(6):653-7.
Score: 0.002